Myoung-Ok Kwon
Directeur/Membre du Conseil chez Medimaps Group SA
Profil
Myoung-Ok Kwon is the founder of Julier Partners GmbH, founded in 2013.
Currently, Dr. Kwon is a Director at Medimaps Group SA since 2022.
Dr. Kwon's former positions include Director at ImVision Therapeutics, Inc. from 2007 to 2012, Director at TRACON Pharmaceuticals, Inc. from 2011 to 2012, Director-Executive Board at ImVisioN Therapeutics AG, Asset Manager at PMG Investment Solutions AG from 2018 to 2021, and Managing Partner at Nextech Invest AG from 2007 to 2013.
Dr. Kwon's education includes a doctorate from the University of Basel and a doctorate from the Friedrich Miescher Institute.
Dr. Kwon was also an Independent Director at NLS Pharmaceutics Ltd.
from 2021 to 2023.
Postes actifs de Myoung-Ok Kwon
| Sociétés | Poste | Début |
|---|---|---|
Medimaps Group SA
 Medimaps Group SA Packaged SoftwareTechnology Services Medimaps Group SA designs and provides medical tools. The company is headquartered in Plan-les-Ouates, Switzerland. | Directeur/Membre du Conseil | 28/11/2022 |
Anciens postes connus de Myoung-Ok Kwon
| Sociétés | Poste | Fin |
|---|---|---|
| NLS PHARMACEUTICS LTD. | Directeur/Membre du Conseil | 22/05/2023 |
PMG Investment Solutions AG
 PMG Investment Solutions AG Investment ManagersFinance Part of Swiss Pension & Investment Group AG, PMG Investment Solutions AG is an independent Swiss fund management company based in Zurich, Switzerland. With almost 20 years of experience, PMG provides a range of fund management services, including administration and individualized solutions for funds in Switzerland and abroad. The company was founded in 1992, and the CEO is Bernhard Schneider. | Gestionnaire de Portefeuille-Actions | 01/01/2021 |
ImVisioN Therapeutics AG
 ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services ImVisioN Therapeutics AG is a Swiss, clinical stage immunotherapy company developing novel treatments to cure allergies. The Company is the pioneer in intralymphatic immunotherapy (ILIT ™), a proprietary technology for the delivery of immunotherapeutics in the treatment of allergies. ILIT ™ is clinically proven and has been shown to be a safer, more efficacious and more convenient means of delivering allergy therapeutics. By applying another proprietary technology, Modular Antigen Transportation ™ (MAT ™), ImVisioN leverages the potential of ILIT ™ to develop drugs that use allergens safely for specific and highly effective antigen presentation. ImVisioN's lead product is for the treatment of cat dander allergy and the Company has programs addressing birch pollen and house dust mite allergies. The Company's proprietary technology platforms are applicable to further allergy targets, which may be addressed in the future. | Corporate Officer/Principal | 13/02/2014 |
Nextech Invest AG
 Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Directeur en chef des Investissements | 13/09/2013 |
| TRACON PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/01/2012 |
Formation de Myoung-Ok Kwon
| University of Basel | Doctorate Degree |
| Friedrich Miescher Institute | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| NLS PHARMACEUTICS LTD. | Health Technology |
| Entreprise privées | 6 |
|---|---|
ImVision Therapeutics, Inc.
 ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImVision Therapeutics, Inc. develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies. The company was founded on January 28, 2005 and is headquartered in Hanover, Germany. | Health Technology |
PMG Investment Solutions AG
PMG Investment Solutions AG Investment ManagersFinance Part of Swiss Pension & Investment Group AG, PMG Investment Solutions AG is an independent Swiss fund management company based in Zurich, Switzerland. With almost 20 years of experience, PMG provides a range of fund management services, including administration and individualized solutions for funds in Switzerland and abroad. The company was founded in 1992, and the CEO is Bernhard Schneider. | Finance |
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals. | Finance |
ImVisioN Therapeutics AG
ImVisioN Therapeutics AG Miscellaneous Commercial ServicesCommercial Services ImVisioN Therapeutics AG is a Swiss, clinical stage immunotherapy company developing novel treatments to cure allergies. The Company is the pioneer in intralymphatic immunotherapy (ILIT ™), a proprietary technology for the delivery of immunotherapeutics in the treatment of allergies. ILIT ™ is clinically proven and has been shown to be a safer, more efficacious and more convenient means of delivering allergy therapeutics. By applying another proprietary technology, Modular Antigen Transportation ™ (MAT ™), ImVisioN leverages the potential of ILIT ™ to develop drugs that use allergens safely for specific and highly effective antigen presentation. ImVisioN's lead product is for the treatment of cat dander allergy and the Company has programs addressing birch pollen and house dust mite allergies. The Company's proprietary technology platforms are applicable to further allergy targets, which may be addressed in the future. | Commercial Services |
Medimaps Group SA
Medimaps Group SA Packaged SoftwareTechnology Services Medimaps Group SA designs and provides medical tools. The company is headquartered in Plan-les-Ouates, Switzerland. | Technology Services |
| Julier Partners GmbH |
